Team and Partners
Management Team
Dr. Zhao is an internationally acclaimed scientist and doctor who specializes in immunology and stem cell biology. He is the first scientist to discover the CB-SC stem cells and is the inventor of Stem Cell Educator Therapy. He has held academic and professorship positions at Hackensack Meridian Health and the University of Illinois at Chicago. He holds 10 patents and 60 publications and received his post-doctoral training from the University of Chicago
Dr. Fox received his medical degree from the University of Minnesota in 1975 and his law degree from Santa Clara University in 2009. He is board-certified in Pediatrics and board-eligible in both Pediatric Critical Care Medicine and Pediatric Pulmonology. He has held faculty positions at the University of Colorado and Harvard Medical School. He has published 24 peer-reviewed original scientific papers and numerous abstracts and case reports.
Bruce has led the design and operation of business information systems across medical, commercials, and defense sectors. He created one of the first ecommerce companies, built a multimillion-dollar ecommerce platform for an analytical instrument firm, developed Aetna’s multilingual scheduling system serving 30M+ customers, and engineered billing systems for Alzheimer’s and pediatric clinics.
Seasoned healthcare executive with 35+ years of leadership experience, including 35 years as Chief Executive Officer of a multi-state, highly regulated healthcare organization. Brings deep expertise in healthcare governance, regulatory compliance, quality systems, risk management, and hospital partnerships. Trusted advisor to boards and executive teams on FDA and AATB compliance, ethical donation practices, patient safety, and organizational sustainability. Demonstrated ability to guide organizations operating in complex clinical, regulatory, and community-facing environments.
Dr. Ross was born in California and attended Stanford University on scholarship. She received her medical degree from Cornell University Medical College in New York. Dr. Ross specializes in ophthalmology with a subspecialty in retina and vitreous disorders; she has been an accomplished, board-certified surgeon for 25 years. She came to the University of Arizona in 2018. Her private practice, Global Retina Institute, is focused on personalized eye care. She has 23 peer-reviewed scientific publications.
Board of Directors
Dr. Zhao is an internationally acclaimed scientist and doctor who specializes in immunology and stem cell biology. He is the first scientist to discover the CB-SC stem cells and is the inventor of Stem Cell Educator Therapy. He has held academic and professorship positions at Hackensack Meridian Health and the University of Illinois at Chicago. He holds 10 patents and 60 publications and received his post-doctoral training from the University of Chicago
Dr. Dudka has been a lifelong healthcare industry veteran including roles as an executive strategy consultant for Bristol Myers Squibb, Johnson & Johnson, & Pfizer. He was a fellow at the National Institute of Health and was the President of American College of Neuropsychopharmacology. He was a Professor at Princeton, Rutgers, and State University of New York. His expertise is in full operations-to-market drug launches, HIT and healthcare reengineering. He holds a PhD from Princeton University.
Mr. Ostrov had first-hand experience of the efficacy of Throne’s technology through the treatment of his 13 year old grandson for type 1 diabetes. He was the former Company Group Chairman of Johnson & Johnson’s North America Consumer and Personal Care businesses. He was also the President of CIBA Consumer Pharmaceutical (now Novartis), Company Group Chairman for Johnson & Johnson’s Worldwide Vision Care businesses, and Chairman and CEO of Bausch and Lomb. He received his MBA from Harvard University.
Board of Advisors
William Brown is the Founder and Chairman of Central Garden & Pet, a $3B publicly traded company built through more than 60 acquisitions over the past 30 years. He has been actively involved in human health and longevity for three decades, including investing in and leading drug development efforts across four companies and funds. He holds a BSIE from the University of California, Berkeley, and is a graduate of the Stanford Executive Program.
Director of the Gradus/RSJ Life Sciences Fund; Director of Global Business Development of PrimeCell Therapeutics overseeing the expansion of the largest regenerative medicine company in Central Europe; Analyst and advisor to Amgen, Novartis, Eli Lilly, Allergan, EMD, Serono and Sanofi; MD from the Medical Faculty of Charles University in Prague
Recognized medical authority in diabetes; Head of the Diabetes Sect. at the Hospital Universitario Central de Asturias, Oviedo, Spain; Vice Dean at the Uni. of Oviedo School of Med.; VP of the Spanish Society of Endocrinology and Nutrition (SEEN); Corresponding Academician of the Royal Academy of Med. of the Principality of Asturias.
Accomplished healthcare veteran with special personal interests in a diabetes cure; Board Director at Boston Scientific; Chairman of the Board and CEO of Becton, Dickinson, and Company (BDX); Senior auditor at PWC; Board Director of CVS Health; Board of trustees at Hackensack University Med.; MBA from Columbia University